logo-loader
viewFastjet PLC

fastjet shares nosedive as it warns it could go bust by the end of the month

It is not the first time fastjet has said it needs more money, but it remains to be seen if lenders will be willing step up once again

fastjet plane
fastjet was founded by Sir Stelios, the Greek billionaire behind easyJet

fastjet PLC (LON:FJET), the low-cost African airline set up by easyJet PLC (LON:EZJ) founder Sir Stelios Haji-Ioannou, has once again warned it will go bust if investors don’t stump up some more money.

The ambitious carrier set out to be the continent’s first low-cost pan-African airline, but it has struggled to gain traction in its target markets.

READ: fastjet warns it could go bust

As a result, it has been burning through cash at a rate of knots and said back in June that it would collapse if a fresh injection of cash wasn’t forthcoming.

Luckily, it managed to get away a £5.3mln placing a few days after which kept it afloat over summer, but it has now run into more troubles.  

fastjet said today (Friday) it needs to either carry out another fundraiser or reach an agreement with its main creditors in the coming days otherwise “it would be unable to continue as a going concern”.

Some cost-cutting and a slight pick-up in trading mean it has enough cash to limp on through until the end of the month although the funds are unlikely to stretch much further.

Discussions ongoing

“Whilst discussions to date with certain shareholders and creditors have been positive, discussions are ongoing and there can be no guarantee of a successful outcome,” read this morning’s statement.

“If the company is unable to carry out an equity fundraise and/or reach an agreement with its key creditors, the Group would be unable to continue trading as a going concern.”

Shares were down another 12.6% to 1.53p on Friday morning, valuing the company at less than £10mln. At one point back in 2006, shares were worth almost 9,000p.

Quick facts: Fastjet PLC

Price: 0.09 GBX

AIM:FJET
Market: AIM
Market Cap: £3.12 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Medexus Pharmaceuticals pleased with recent Aptevo BioTherapeutics...

Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQB:PDDPF) CEO Ken d’Entremont tells Proactive he's pleased with the value the acquisition of hematology asset IXINITY has provided to Medexus, and that it is well positioned to emerge stronger when the economy reopens after the coronavirus crisis....

15 hours, 37 minutes ago

2 min read